Ocugen ( NASDAQ:OCGN – Get Rating ) and Bio-Techne ( NASDAQ:TECH – Get Rating ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Institutional & Insider Ownership 37.5% of Ocugen shares are owned by institutional investors. Comparatively, 23.9% of Bio-Techne shares are owned by institutional investors. 2.8% of Ocugen shares are owned by insiders.

https://www.dailypolitical.com/2023/05/30/head-to-head-contrast-ocugen-nasdaqocgn-bio-techne-nasdaqtech.html

#dailypolitical